Influence of PSA level at salvage radiotherapy on metastasis-free survival following radical prostatectomy - Top-Institutions - MDSpire

Influence of PSA level at salvage radiotherapy on metastasis-free survival following radical prostatectomy

  • By

  • Mike Wenzel

  • Benedikt Lauer

  • Kathrin Burdenski

  • Nikolaos Tselis

  • Claus Rödel

  • Christian Brandts

  • Marit Ahrens

  • Jens Köllermann

  • Markus Graefen

  • Clara Humke

  • Carolin Siech

  • Benedikt Hoeh

  • Felix K. H. Chun

  • Philipp Mandel

  • November 21, 2025

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Radiation Oncology
    • Clinical Research

  • #2

    University Hospital Frankfurt, University Cancer Center Frankfurt (UCT)
    University Hospital Frankfurt, University Cancer Center Frankfurt (UCT)

    Frankfurt, Hesse

    Key Differentiators

    • Urology
    • Radiation Oncology
    • Oncologic Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Urologic Oncology

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Cancer Research

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Radiation Oncology
    • Clinical Oncology

Original Source(s)

Influence of PSA level at salvage radiotherapy on metastasis-free survival following radical prostatectomy

  • by Mike Wenzel, Benedikt Lauer, Kathrin Burdenski, Nikolaos Tselis, Claus Rödel, Christian Brandts, Marit Ahrens, Jens Köllermann, Markus Graefen, Clara Humke, Carolin Siech, Benedikt Hoeh, Felix K. H. Chun, Philipp Mandel

  • November 21, 2025

Related Content

Dana-Farber Research News 03.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 16 - 28.

  • by

  • March 15, 2026

  • 21 min
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

Radiotherapy in metastatic bladder cancer